Key Points
- Insider buying: ConvaTec Group insider Jonny Mason purchased 50,000 shares on May 26 at GBX 201 each, a transaction worth about £100,500.
- Recent insider selling: Mason also sold 291,149 shares on March 16 at an average price of GBX 234, for total proceeds of about £681,289.
- Analyst outlook remains mostly positive: The stock has eight Buy ratings and one Hold, with a consensus price target of GBX 308.78, even though some brokers recently trimmed their targets.
ConvaTec Group PLC (LON:CTEC - Get Free Report) insider Jonny Mason acquired 50,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was purchased at an average price of GBX 201 per share, with a total value of £100,500.
Jonny Mason also recently made the following trade(s):
- On Monday, March 16th, Jonny Mason sold 291,149 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 234, for a total value of £681,288.66.
ConvaTec Group Price Performance
Shares of CTEC stock opened at GBX 202.80 on Thursday. The stock has a 50-day moving average price of GBX 218.45 and a 200 day moving average price of GBX 229.73. The company has a quick ratio of 0.96, a current ratio of 1.53 and a debt-to-equity ratio of 106.19. The firm has a market cap of £3.96 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 0.93 and a beta of 0.78. ConvaTec Group PLC has a 12 month low of GBX 195.90 and a 12 month high of GBX 311.20.
Analyst Ratings Changes
A number of brokerages recently commented on CTEC. Citigroup lowered their price objective on ConvaTec Group from GBX 250 to GBX 230 and set a "neutral" rating for the company in a research report on Monday, May 18th. Jefferies Financial Group reiterated a "buy" rating and issued a GBX 325 price objective on shares of ConvaTec Group in a research report on Friday, May 15th. UBS Group reiterated a "buy" rating and issued a GBX 375 price objective on shares of ConvaTec Group in a research report on Monday, May 18th. JPMorgan Chase & Co. lowered their price objective on ConvaTec Group from GBX 307 to GBX 294 and set an "overweight" rating for the company in a research report on Friday, May 22nd. Finally, Berenberg Bank reiterated a "buy" rating and issued a GBX 340 price objective on shares of ConvaTec Group in a research report on Tuesday, April 21st. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of GBX 308.78.
Check Out Our Latest Research Report on ConvaTec Group
About ConvaTec Group
(
Get Free Report)
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
